
 
													
 
									 
															 
															Year
 
															DEALS // DEV.
 
															Country
 
															 
															Therapeutic Area
 
															Study Phase
 
															Deal Type
 
															Product Type
 
															Dosage Form
 
															Lead Product
 
															Target

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Levomefolate
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase II/ Phase III
Sponsor : Pamlab
Deal Size : Inapplicable
Deal Type : Inapplicable
L-methylfolate Supplementation to OROS-Methylphenidate Pharmacotherapy in ADHD Adults
Details : L-Methylfolate is a Other Small Molecule drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Attention Deficit Disorder with Hyperactivity.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 14, 2013
Lead Product(s) : Levomefolate
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase II/ Phase III
Sponsor : Pamlab
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Levomefolate
Therapeutic Area : Endocrinology
Study Phase : Undisclosed
Sponsor : Goldfarb Foundation | Pamlab
Deal Size : Inapplicable
Deal Type : Inapplicable
Metanx Effects on Nerve Fiber Density in Neuropathic Diabetics
Details : L-Methylfolate is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Diabetes Mellitus.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 04, 2012
Lead Product(s) : Levomefolate
Therapeutic Area : Endocrinology
Highest Development Status : Undisclosed
Sponsor : Goldfarb Foundation | Pamlab
Deal Size : Inapplicable
Deal Type : Inapplicable

 Reset All
Reset All